Makhoul, Issam <br/><br/>
High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer.  [electronic resource] 

 -  American journal of clinical oncology  06 2016 
 - 248-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1537-453X 
<br/><br/><label>Standard No.: </label>10.1097/COC.0000000000000046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiopoietin-1--blood<br/>Angiopoietin-2--blood<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Becaplermin<br/>Bevacizumab--administration & dosage<br/>Biomarkers, Tumor--blood<br/>Breast Neoplasms--chemistry<br/>Carcinoma, Ductal, Breast--chemistry<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Docetaxel<br/>Doxorubicin--administration & dosage<br/>Female<br/>Fibroblast Growth Factor 2--blood<br/>Humans<br/>Interleukin-1alpha--blood<br/>Matrix Metalloproteinase 9--blood<br/>Neoadjuvant Therapy<br/>Neovascularization, Pathologic--drug therapy<br/>Platelet Endothelial Cell Adhesion Molecule-1--blood<br/>Platelet-Derived Growth Factor--metabolism<br/>Prospective Studies<br/>Proto-Oncogene Proteins c-sis--blood<br/>Receptor, ErbB-2--analysis<br/>Receptor, TIE-2--blood<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>Taxoids--administration & dosage<br/>Vascular Endothelial Growth Factor A--blood<br/>Vascular Endothelial Growth Factor Receptor-2--blood